Upload Image (Max 20MB per Image)
The US FDA has approved Warner Chilcott's 400mg mesalamine product as new ulcerative colitis therapy, to be marketed as Delzicol. Warner expects to commercially launch Delzicol in March 2013. Delzicol delayed-release capsules are ...
Tags: FDA, Warner Delzicol, ulcerative colitis therapy